Healio4h
Top in cardiology: Heart disease remains leading cause of death; low-value aspirin use
The American Heart Association has issued its heart disease and stroke statistical update for 2025, which provides an ...
Medscape4d
Ross Procedure Making a Comeback in Aortic Valve Disease
New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...
Edwards Lifesciences upped to Buy at Stifel on TAVR growth
Edwards Lifesciences (NYSE:EW) traded higher on Thursday after Stifel upgraded the heart device maker to Buy from Hold, citing a turnaround in its position in the market for transcatheter aortic valve ...
Healio4d
CABG plus surgical AVR may suit certain older patients with aortic stenosis, CAD
CABG plus surgical aortic valve replacement for treatment of coronary disease and aortic stenosis was associated with better 5-year outcomes vs. PCI plus transcatheter aortic valve replacement in ...
Stifel raises Edwards Lifesciences stock to buy, target to $90
Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also ...